Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome

Gastroenterology.

Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JWT, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D

doi: 10.1053/j.gastro.2019.08.026.

Inflammatory Bowel Disease

Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis

J Crohns Colitis

Ghosh S, Sanchez Gonzalez Y, Zhou W, Clark R, Xie W, Louis E, Loftus EV Jr, Panes J, Danese S

doi: 10.1093/ecco-jcc/jjab099

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Aliment Pharmacol Ther.

Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ

doi: 10.1111/apt.15077.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation

Dig Dis Sci.

Bouchoucha M, Devroede G, Mary F, Bon C, Bejou B, Benamouzig R

doi: 10.1007/s10620-018-4995-6.

Gastrointestinal Diseases

Opioid Use and Potency are Associated with Clinical Features, Quality of Life, and Use of Resources in Patients with Gastroparesis

Clin Gastroenterol Hepatol.

Hasler WL, Wilson LA, Nguyen LA, Snape WJ, Abell TL, Koch KL, McCallum RW, Pasricha PJ, Sarosiek I, Farrugia G, Grover M, Lee LA, Miriel L, Tonascia J, Hamilton FA, Parkman HP, Gastroparesis Clinical Research Consortium (GpCRC)

doi: 10.1016/j.cgh.

Hepatitis

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial

Lancet Gastroenterol Hepatol.

Asselah T, Lee SS, Yao BB, Nguyen T, Wong F, Mahomed A, Lim SG, Abergel A, Sasadeusz J, Gane E, Zadeikis N, Schnell G, Zhang Z, Porcalla A, Mensa FJ, Nguyen K

doi: 10.1016/S2468-

RECOMMENDED

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Am J Gastroenterol.

Chey WD, Lembo AJ, Rosenbaum DP

doi: 10.14309/ajg.0000000000000516.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study

Am J Gastroenterol.

Shah ED, Almario CV, Spiegel BM, Chey WD

doi: 10.14309/ajg.0000000000000502.

Inflammatory Bowel Disease

Efficacy and Speed of Induction of Remission of Infliximab vs Golimumab for Patients With Ulcerative Colitis, Based on Data From Clinical Trials

Clin Gastroenterol Hepatol.

Singh S, Proudfoot JA, Dulai PS, Xu R, Feagan BG, Sandborn WJ, Jairath V

doi: 10.1016/j.cgh.2019.05.019.

Related content

Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome

Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation

Opioid Use and Potency are Associated with Clinical Features, Quality of Life, and Use of Resources in Patients with Gastroparesis

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)

Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study

Efficacy and Speed of Induction of Remission of Infliximab vs Golimumab for Patients With Ulcerative Colitis, Based on Data From Clinical Trials